menu
    • menu

    Company profile for Taiho Pharmaceutical

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In 1969, Taiho Pharmaceutical’s first president, Yukio Kobayashi, visited the former Soviet Union for business discussions on Pantocrin Injection, a drug to ameliorate general malaise for which demand had suddenly started to increase at the time.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Taiho Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    1-27 Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444
    Telephone
    Telephone
    +81-3-3294-4527
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.taiho.co.jp/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC
    Taiho, Cullinan Start NDA Submission For Zipalertinib In NSCLC

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-taiho-pharmaceutical-and-cullinan-therapeutics-initiate-rolling-submission-of-new-drug-application-to-us-food-and-drug-administration-for-zipalertinib-for-treatment-of-locally-advanced-or-metastatic-non-small-cel-302621302.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Taiho Pharma Opts For Exclusive License Of Casdatifan In Japan
    Taiho Pharma Opts For Exclusive License Of Casdatifan In Japan

    19 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251019482380/en/Taiho-Pharmaceutical-Exercises-Option-for-an-Exclusive-License-to-Casdatifan-in-Japan-and-Certain-Territories-in-Asia

    BUSINESSWIRE
    19 Oct 2025
    Share Share
    Taiho’s Inqovi Combo sNDA Accepted By US FDA For AML
    Taiho’s Inqovi Combo sNDA Accepted By US FDA For AML

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-taiho-pharmaceutical-announce-us-fda-acceptance-of-supplemental-new-drug-application-for-inqovi-in-combination-with-venetoclax-to-treat-patients-with-acute-myeloid-leukemia-302501545.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Taiho’s DMD asset misses in phase 3 trial
    Taiho’s DMD asset misses in phase 3 trial

    09 Jul 2025

    // PRESS RELEASE

    https://www.taiho.co.jp/en/release/2025/20250708.html

    PRESS RELEASE
    09 Jul 2025
    Share Share
    Taiho's DMD Asset Fails in Phase 3 Trial
    Taiho's DMD Asset Fails in Phase 3 Trial

    08 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/taihos-dmd-asset-fails-improve-functional-motor-test-results-phase-3-trial

    FIERCE BIOTECH
    08 Jul 2025
    Share Share
    Taiho & Cullinan Announce Phase 1/2 Data Published
    Taiho & Cullinan Announce Phase 1/2 Data Published

    01 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-announce-pivotal-rezilient1-phase-12-data-published-in-the-journal-of-clinical-oncology-302470143.html

    PR NEWSWIRE
    01 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Contact Taiho Pharmaceutical and get a quotation

    Taiho Pharmaceutical is a supplier offers 9 products (APIs, Excipients or Intermediates).

    Find a price of Tipiracil Hydrochloride bulk with DMF offered by Taiho Pharmaceutical

    Find a price of Trifluridine bulk with DMF offered by Taiho Pharmaceutical

    Find a price of 2 1H-Pyridinone 5-Chloro-4-Hydroxy bulk offered by Taiho Pharmaceutical

    Find a price of 3-2,4-Dimethoxybenzylidene-Anabaseine bulk offered by Taiho Pharmaceutical

    Find a price of Suplatast Tosilate bulk offered by Taiho Pharmaceutical

    Find a price of Tac 101 bulk offered by Taiho Pharmaceutical

    Find a price of Tegafur bulk offered by Taiho Pharmaceutical

    Find a price of TAS-103 bulk offered by Taiho Pharmaceutical

    Find a price of Gimeracil bulk offered by Taiho Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search